Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.Start Printed Page 16221
Name of Committee: National Institute on Drug Abuse Special Emphasis Panel; NO1DA-9-8881: GMP Synthesis of Bulk Drug Substances.
Date: May 13, 2009.
Time: 9 a.m. to 5 p.m.
Agenda: To review and evaluate contract proposals.
Place: Doubletree Hotel Bethesda, 8120 Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Minna Liang, PhD, Scientific Review Officer, Training and Special Projects Review Branch, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, 6101 Executive Blvd., Room 220, MSC 8401, Bethesda, MD 20852, 301-435-1432, firstname.lastname@example.org.
(Catalogue of Federal Domestic Assistance Program Nos. 93.279, Drug Abuse and Addiction Research Programs, National Institutes of Health, HHS)Start Signature
Dated: March 31, 2009.
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-7728 Filed 4-8-09; 8:45 am]
BILLING CODE 4140-01-M